Índice

• • ·Building a more resilient cancer healthcare system

    Página :999

     
• • ·Cancer diagnostic delay in the COVID-19 era: what happens next?

    Página :1000-1002

    William Hamilton

     
• • ·TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?

    Página :1002-1003

    Emmanuelle Samalin, Antoine Adenis

     
• • ·Lenvatinib and pembrolizumab in advanced gastric cancer

    Página :1004-1005

    Stefano Cascinu

     
• • ·Cabozantinib as a choice for platinum-refractory metastatic urothelial cancer

    Página :1005-1006

    Eiji Kikuchi, Nozomi Hayakawa

     
• • ·Cancer care in the Commonwealth Caribbean in COVID times

    Página :1007-1009

    Glennis Andall-Brereton, Brittany Bromfield, Steven Smith, Dingle Spence

     
• • ·100 European core quality standards for cancer care and research centres

    Página :1009-1011

    Simon Oberst, Wim van Harten, Gunnar Sæter, Paolo de Paoli, Péter Nagy, Jean-Benoit Burrion, József Lovey, Thierry Philip

      
• • ·Should we worry about residual disease after mastectomy?

    Página :1011-1013

    Orit Kaidar-Person, Thorsten Kühn, Philip Poortmans

      
• • ·Clinical development of immuno-oncology in China

    Página :1013-1016

    Da-Wei Wu, Hui-Yao Huang, Yu Tang, Yang Zhao, Zhi-Min Yang, Jun Wang, Shu-Hang Wang, Yue Yu, Yuan Fang, Hong Fang, Ying Bai, Chao Sun, Qi Fan, An-Qi Yu, Huan-Ling Wang, Chun-Xia Du, Kun Chen, Ming-De Huang, Yin Zhang, Ning Li, Bing-He Xu, Yan Sun, Jie He

     
• • ·Ivosidenib for advanced IDH1-mutant cholangiocarcinoma

    Página :e370

    Lorenzo Gervaso, Stefania Pellicori, Nicola Fazio

    
• • ·Ivosidenib for advanced IDH1-mutant cholangiocarcinoma – Authors’ reply

    Página :e371

    Ghassan K Abou-Alfa, Shuchi S Pandya, Andrew X Zhu

    
• • ·Correction to Lancet Oncol 2019; 20: 1556–65

    Página :e372

    
• • ·Correction to Lancet Oncol 2019; 20: 1474–76

    Página :e372

    
• • ·Correction to Lancet Oncol 2019; 20: e658

    Página :e372

    
• • ·Correction to Lancet Oncol 2020; 21: 271–82

    Página :e372

    
• • ·Correction to Lancet Oncol 2020; 21: e317–29

    Página :e372

    
• • ·Correction to Lancet Oncol 2020; 21: e330–36

    Página :e372

    
• • ·Correction to Lancet Oncol 2020; 21: 947–56

    Página :e373

    
• • ·Correction to Lancet Oncol 2020; 21: e338

    Página :e373

    
• • ·Carcinogenicity of some aromatic amines and related compounds

    Página :1017-1018

    IARC Monographs Vol 127 group, David M. DeMarini, Tania Carreón-Valencia, William M. Gwinn, Nancy B. Hopf, Martha S. Sandy, Tina Bahadori, Gloria M. Calaf, Guosheng Chen, Aline de Conti, Lin Fritschi, Min Gi, P. David Josephy, Jorunn Kirkeleit, Kristina Kjaerheim, Sophie Langouët, Damien M. McElvenny, Consolato M. Sergi, Leslie T. Stayner, Takeshi Toyoda, Yann Grosse, Lamia Benbrahim-Tallaa, Fatiha El Ghissassi, Eero Suonio, Michelle C. Turner, Ian A. Cree, Heidi Mattock, Karen Müller, Felicia Chung, Kathryn Z. Guyton, Mary K. Schubauer-Berigan

    
• • ·Expanding access to radiotherapy in sub-Saharan Africa

    Página :1019

    Rebecca Barksby

     
• • ·Organisations for patients with cancer feel the brunt of COVID-19 pandemic

    Página :1020

    Roxanne Nelson

     
• • ·Disruption of cancer care in Canada during COVID-19

    Página :e374

    Sherene Chen-See

    Esquema Esquema  
• • ·First case of osteosarcoma in a dinosaur: a multimodal diagnosis

    Página :1021-1022

    Seper Ekhtiari, Kentaro Chiba, Snezana Popovic, Rhianne Crowther, Gregory Wohl, Andy Kin On Wong, Darren H Tanke, Danielle M Dufault, Olivia D Geen, Naveen Parasu, Mark A Crowther, David C Evans

      
• • ·The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

    Página :1023-1034

    Camille Maringe, James Spicer, Melanie Morris, Arnie Purushotham, Ellen Nolte, Richard Sullivan, Bernard Rachet, Ajay Aggarwal

    Resumen Resumen Esquema Esquema   
• • ·Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study

    Página :1035-1044

    Amit Sud, Bethany Torr, Michael E Jones, John Broggio, Stephen Scott, Chey Loveday, Alice Garrett, Firza Gronthoud, David L Nicol, Shaman Jhanji, Stephen A Boyce, Matthew Williams, Elio Riboli, David C Muller, Emma Kipps, James Larkin, Neal Navani, Charles Swanton, Georgios Lyratzopoulos, Ethna McFerran, Mark Lawler, Richard Houlston, Clare Turnbull

    Resumen Resumen Esquema Esquema   
• • ·S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial

    Página :1045-1056

    Yoon-Koo Kang, Keisho Chin, Hyun Cheol Chung, Shigenori Kadowaki, Sang Cheul Oh, Norisuke Nakayama, Keun-Wook Lee, Hiroki Hara, Ik-Joo Chung, Masahiro Tsuda, Se Hoon Park, Hisashi Hosaka, Shuichi Hironaka, Yoshinori Miyata, Min-Hee Ryu, Hideo Baba, Ichinosuke Hyodo, Yung-Jue Bang, Narikazu Boku

    Resumen Resumen Esquema Esquema   
• • ·Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial

    Página :1057-1065

    Akihito Kawazoe, Shota Fukuoka, Yoshiaki Nakamura, Yasutoshi Kuboki, Masashi Wakabayashi, Shogo Nomura, Yuichi Mikamoto, Hikari Shima, Noriko Fujishiro, Tsukiko Higuchi, Akihiro Sato, Takeshi Kuwata, Kohei Shitara

    Resumen Resumen Esquema Esquema   
• • ·Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial

    Página :1066-1076

    Daniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, Hope E Uronis, Keun-Wook Lee, Matthew C H Ng, Peter C Enzinger, Se Hoon Park, Philip J Gold, Jill Lacy, Howard S Hochster, Sang Cheul Oh, Yeul Hong Kim, Kristen A Marrone, Ronan J Kelly, Rosalyn A Juergens, Jong Gwang Kim, Johanna C Bendell, Thierry Alcindor, Sun Jin Sym, Eun-Kee Song, Cheng Ean Chee, Yee Chao, Sunnie Kim, A Craig Lockhart, Keith L Knutson, Jennifer Yen, Aleksandra Franovic, Jeffrey L Nordstrom, Daner Li, Jon Wigginton, Jan K Davidson-Moncada, Minori Koshiji Rosales, Yung-Jue Bang, CP-MGAH22-5 Study Group

    Resumen Resumen Esquema Esquema   
• • ·Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis

    Página :1077-1088

    Zachary J Ward, Andrew M Scott, Hedvig Hricak, May Abdel-Wahab, Diana Paez, Miriam Mikhail Lette, H Alberto Vargas, T Peter Kingham, Rifat Atun

    Resumen Resumen Esquema Esquema   
• • ·The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis

    Página :1089-1098

    Zachary J Ward, Surbhi Grover, Andrew M Scott, Sungmin Woo, Dina H Salama, Elizabeth C Jones, Tarek El-Diasty, Bradley R Pieters, Edward L Trimble, H Alberto Vargas, Hedvig Hricak, Rifat Atun

    Resumen Resumen Esquema Esquema  
• • ·Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

    Página :1099-1109

    Andrea B Apolo, Rosa Nadal, Yusuke Tomita, Nicole N Davarpanah, Lisa M Cordes, Seth M Steinberg, Liang Cao, Howard L Parnes, Rene Costello, Maria J Merino, Les R Folio, Liza Lindenberg, Mark Raffeld, Jeffrey Lin, Min-Jung Lee, Sunmin Lee, Sylvia V Alarcon, Akira Yuno, Nancy A Dawson, Kimaada Allette, Arpita Roy, Dinuka De Silva, Molly M Lee, Tristan M Sissung, William D Figg, Piyush K Agarwal, John J Wright, Yangmin M Ning, James L Gulley, William L Dahut, Donald P Bottaro, Jane B Trepel

    Resumen Resumen Esquema Esquema   
• • ·Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial

    Página :1110-1122

    Aaron R Weiss, Yen-Lin Chen, Thomas J Scharschmidt, Yueh-Yun Chi, Jing Tian, Jennifer O Black, Jessica L Davis, Julie C Fanburg-Smith, Eduardo Zambrano, James Anderson, Robin Arens, Odion Binitie, Edwin Choy, Justin W Davis, Andrea Hayes-Jordan, Simon C Kao, Mark L Kayton, Sandy Kessel, Ruth Lim, William H Meyer, Lynn Million, Scott H Okuno, Andrew Ostrenga, Marguerite T Parisi, Daniel A Pryma, R Lor Randall, Mark A Rosen, Mary Schlapkohl, Barry L Shulkin, Ethan A Smith, Joel I Sorger, Stephanie Terezakis, Douglas S Hawkins, Sheri L Spunt, Dian Wang

    Resumen Resumen Esquema Esquema   
• • ·Knowledge gaps in oncoplastic breast surgery

    Página :e375

    Walter P Weber, Monica Morrow, Jana de Boniface, Andrea Pusic, Giacomo Montagna, Elisabeth A Kappos, Mathilde Ritter, Martin Haug, Christian Kurzeder, Ramon Saccilotto, Alexandra Schulz, John Benson, Florian Fitzal, Zoltan Matrai, Jane Shaw, Marie-Jeanne Vrancken Peeters, Shelley Potter, Joerg Heil, Oncoplastic Breast Consortium, Eduardo González, Mona Elzayat, Rupert Koller, Michael Gnant, Fabricio Brenelli, Regis Resende Paulinelli, Vappu Zobel, Sarianna Joukainen, Ulla Karhunen-Enckell, Susanna Kauhanen, Jean-Marc Piat, Vesna Bjelic-Radisic, Andree Faridi, Christoph Heitmann, Juergen Hoffmann, Ulrich Kneser, Sherko Kümmel, Thorsten Kühn, Michalis Kontos, Ekaterini Christina Tampaki, Mitchel Barry, Tanir M Allweis, Moshe Carmon, Tal Hadar, Giuseppe Catanuto, Carlos A Garcia-Etienne, Oreste D Gentilini, Susan Knox, Barbara Klein, Linetta Koppert, Pedro F Gouveia, Tor Svensjö, Heiner C Bucher, Silvia Ess, Ursula Ganz-Blättler, Andreas Günthert, Nik Hauser, Nancy Hynes, Michael Knauer, Marlen Pfeiffer, Christoph Rochlitz, Christoph Tausch, Yves Harder, Frank Zimmermann, Fabienne D Schwab, Veronica D’Amico, Savas D Soysal, Liliana Castrezana Lopez, Ilario Fulco, Lars G Hemkens, Visnu Lohsiriwat, Bahadir M Gulluoglu, Guldeniz Karadeniz, Hasan Karanlik, Atakan Sezer, Mehmet Ali Gulcelik, Mustafa Emiroglu, Tibor Kovacs, Tim Rattay, Laszlo Romics, Raghavan Vidya, Lynda Wyld, Mahmoud El-Tamer, Virgilio Sacchini

    Resumen Resumen Esquema Esquema   
• • ·Hereditary diffuse gastric cancer: updated clinical practice guidelines

    Página :e386

    Vanessa R Blair, Maybelle McLeod, Fátima Carneiro, Daniel G Coit, Johanna L D’Addario, Jolanda M van Dieren, Kirsty L Harris, Nicoline Hoogerbrugge, Carla Oliveira, Rachel S van der Post, Julie Arnold, Patrick R Benusiglio, Tanya M Bisseling, Alex Boussioutas, Annemieke Cats, Amanda Charlton, Karen E Chelcun Schreiber, Jeremy L Davis, Massimiliano di Pietro, Rebecca C Fitzgerald, James M Ford, Kimberley Gamet, Irene Gullo, Richard H Hardwick, David G Huntsman, Pardeep Kaurah, Sonia S Kupfer, Andrew Latchford, Paul F Mansfield, Takeshi Nakajima, Susan Parry, Jeremy Rossaak, Haruhiko Sugimura, Magali Svrcek, Marc Tischkowitz, Toshikazu Ushijima, Hidetaka Yamada, Han-Kwang Yang, Adrian Claydon, Joana Figueiredo, Karyn Paringatai, Raquel Seruca, Nicola Bougen-Zhukov, Tom Brew, Simone Busija, Patricia Carneiro, Lynn DeGregorio, Helen Fisher, Erin Gardner, Tanis D Godwin, Katharine N Holm, Bostjan Humar, Caroline J Lintott, Elizabeth C Monroe, Mark D Muller, Enrique Norero, Yasmin Nouri, Joana Paredes, João M Sanches, Emily Schulpen, Ana S Ribeiro, Andrew Sporle, James Whitworth, Liying Zhang, Anthony E Reeve, Parry Guilford

    Resumen Resumen Esquema Esquema   
• • ·Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research

    Página :e398

    Douglas B Johnson, Kerry L Reynolds, Ryan J Sullivan, Justin M Balko, James R Patrinely, Laura C Cappelli, Jarushka Naidoo, Javid J Moslehi

    Resumen Resumen Esquema Esquema   
• • ·Skull base lymphoma with panhypopituitarism

    Página :e405

    Marvin Rios, Matthew P Wahl, Debra L Simmons, Amnon Schlegel